EDGAR Filing Documents for 0001047469-17-005193

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001047469-17-005193

Filing Date

2017-08-11

Accepted

2017-08-10 21:15:06

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B5	a2232967z424b5.htm	424B5	388174
2	G643877.JPG	g643877.jpg	GRAPHIC	10723
3	G998644.JPG	g998644.jpg	GRAPHIC	15955
4	G249782.JPG	g249782.jpg	GRAPHIC	13298
	Complete submission text file	0001047469-17-005193.txt		444603

Mailing Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355

Business Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355 484-321-5554

Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)